These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 7148709)

  • 1. Effects of verapamil on the electrophysiologic properties of the accessory pathway in patients with the Wolff-Parkinson-White syndrome.
    Harper RW; Whitford E; Middlebrook K; Federman J; Anderson S; Pitt A
    Am J Cardiol; 1982 Dec; 50(6):1323-30. PubMed ID: 7148709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the ventricular response during atrial fibrillation in patients with enhanced atrioventricular node conduction and Wolff-Parkinson-White syndrome.
    Milstein S; Klein GJ; Rattes MF; Sharma AD; Yee R
    J Am Coll Cardiol; 1987 Dec; 10(6):1244-8. PubMed ID: 3680792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Electrophysiologic effects of lorcainide on the accessory pathway in the Wolff-Parkinson-White syndrome.
    Kasper W; Treese N; Meinertz T; Jähnchen E; Pop T
    Am J Cardiol; 1983 Jun; 51(10):1618-22. PubMed ID: 6858867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acceleration of the ventricular response during atrial fibrillation in the Wolff-Parkinson-White syndrome after verapamil.
    Gulamhusein S; Ko P; Carruthers SG; Klein GJ
    Circulation; 1982 Feb; 65(2):348-54. PubMed ID: 7053894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Susceptibility to atrial fibrillation and ventricular tachyarrhythmia in the Wolff-Parkinson-White syndrome: role of the accessory pathway.
    Waspe LE; Brodman R; Kim SG; Fisher JD
    Am Heart J; 1986 Dec; 112(6):1141-52. PubMed ID: 3788760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transesophageal versus intracardiac atrial stimulation in assessing anterograde conduction properties of the accessory pathway in Wolff-Parkinson-White syndrome.
    Favale S; Minafra F; Massari V; Tritto M; Rizzon P
    Int J Cardiol; 1991 Feb; 30(2):209-14. PubMed ID: 2010244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Sotalol in supraventricular tachycardia. Electrophysiologic measurements in Wolff-Parkinson-White syndrome and AV node re-entry tachycardia].
    Manz M; Kuhl AJ; Lüderitz B
    Z Kardiol; 1985 Sep; 74(9):500-5. PubMed ID: 4060827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of propafenone in the Wolff-Parkinson-White syndrome: electrophysiologic findings and long-term follow-up.
    Breithardt G; Borggrefe M; Wiebringhaus E; Seipel L
    Am J Cardiol; 1984 Nov; 54(9):29D-39D. PubMed ID: 6496367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Longitudinal clinical and electrophysiological assessment of patients with symptomatic Wolff-Parkinson-White syndrome and atrioventricular node reentrant tachycardia.
    Chen SA; Chiang CE; Tai CT; Lee SH; Chiou CW; Ueng KC; Wen ZC; Cheng CC; Chang MS
    Circulation; 1996 Jun; 93(11):2023-32. PubMed ID: 8640978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atrial fibrillation in patients with an accessory pathway: importance of the conduction properties of the accessory pathway.
    Della Bella P; Brugada P; Talajic M; Lemery R; Torner P; Lezaun R; Dugernier T; Wellens HJ
    J Am Coll Cardiol; 1991 May; 17(6):1352-6. PubMed ID: 2016453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical efficacy and electrophysiologic effects of intravenous and oral encainide in patients with accessory atrioventricular pathways and supraventricular arrhythmias.
    Abdollah H; Brugada P; Green M; Wehr M; Wellens HJ
    Am J Cardiol; 1984 Sep; 54(6):544-9. PubMed ID: 6433688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Influence of exercise on the permeability of accessory pathways and supraventricular arrhythmia in Wolff-Parkinson-White syndrome].
    Mabo P; Kermarrec A; Gras D; Paillard F; Bédossa M; Daubert C
    Arch Mal Coeur Vaiss; 1992 Oct; 85(10):1443-8. PubMed ID: 1297293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of intracardiac recordings to determine the site of drug action in paroxysmal supraventricular tachycardia.
    Jackman WM; Friday KJ; Fitzgerald DM; Yeung-Lai-Wah JA; Lazzara R
    Am J Cardiol; 1988 Dec; 62(19):8L-19L. PubMed ID: 3059792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Value of transesophageal auricular stimulation for evaluating the accessory pathway and effect of treatment in Wolf-Parkinson-White syndrome].
    Kieny JR; Kraenner C; Facello A; Roul G; Mossard JM; Bareiss P; Sacrez A
    Arch Mal Coeur Vaiss; 1989 Sep; 82(9):1585-93. PubMed ID: 2510679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of amiodarone in the Wolff-Parkinson-White syndrome with rapid ventricular response via accessory pathway during atrial fibrillation.
    Kappenberger LJ; Fromer MA; Steinbrunn W; Shenasa M
    Am J Cardiol; 1984 Aug; 54(3):330-5. PubMed ID: 6465013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Propofol has no direct effect on sinoatrial node function or on normal atrioventricular and accessory pathway conduction in Wolff-Parkinson-White syndrome during alfentanil/midazolam anesthesia.
    Sharpe MD; Dobkowski WB; Murkin JM; Klein G; Yee R
    Anesthesiology; 1995 Apr; 82(4):888-95. PubMed ID: 7717560
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical efficacy and electrophysiologic effects of encainide in patients with Wolff-Parkinson-White syndrome.
    Prystowsky EN; Klein GJ; Rinkenberger RL; Heger JJ; Naccarelli GV; Zipes DP
    Circulation; 1984 Feb; 69(2):278-87. PubMed ID: 6418407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of atropine and isoproterenol on tachycardia induction in asymptomatic patients with Wolff-Parkinson-White electrocardiographic pattern.
    Kim YH; Leitch JW; Klein GJ; Yee R; Leather RA
    Can J Cardiol; 1992 Sep; 8(7):716-20. PubMed ID: 1422992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Electrophysiologic and clinical effects of intravenous and oral encainide in patients with Wolff-Parkinson-White syndrome and paroxysmal atrial fibrillation.
    Chimienti M; Moizi M; Salerno JA; Klersy C; Guasti L; Previtali M; Marangoni E; Montemartini C; Bobba P
    Eur Heart J; 1987 Mar; 8(3):282-90. PubMed ID: 3107987
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Electrophysiologic effects of oral propafenone in Wolff-Parkinson-White syndrome studied by programmed electrical stimulation.
    Sethi KK; Prasad GS; Mohan JC; Arora R; Khalilullah M
    Indian Heart J; 1991; 43(1):5-10. PubMed ID: 1894303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.